Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation

Table 3 Degree of hepatic steatosis in 105 biopsies performed between 12 and 36 mo after the transplant operation (HCV-positive recipients only), in relationship with a selection of variables

	Steatosis
	Absent(n=34)	≤10%(n=60)	>10%(n=11)	P
Ishak staging score ≤2 (n=79)	19	49	11	<0.005
Recipient male gender (n=72)	20	42	10	<0.05
Recipient age≤55 yr (n=50)	15	28	7	NS
Donor age ≤45 yr (n=65)	19	39	7	NS
BMI increase <1.5 kg/m2 (n=76)	29	41	6	<0.05
Recurrent hepatitis C ≤1 yr post-OLT (n=79)	31	41	7	<0.02
Diabetes mellitus (n=31)	10	18	3	NS

BMI: body mass index, OLT: orthotopic liver transplantation, BMI increase: difference between BMI value 1 yr post-OLT and BMI value pre-OLT. P value refers to c² for linear trend.